{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:42:39Z","timestamp":1793943759239,"version":"4.8.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02542-0","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:57:21Z","timestamp":1766401041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Selective genome editing of amplified oncogenes triggers immunogenic cell death and tumor remodeling"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2487-2474","authenticated-orcid":false,"given":"A.","family":"Nieto-Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5535-025X","authenticated-orcid":false,"given":"M.","family":"Martinez-Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7802-4972","authenticated-orcid":false,"given":"P.","family":"Puig-Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Carpintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-7781","authenticated-orcid":false,"given":"A.","family":"Alonso-Yanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6637-671X","authenticated-orcid":false,"given":"P.","family":"Ojeda-Walczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5711-4768","authenticated-orcid":false,"given":"M.","family":"Iba\u00f1ez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2393-0510","authenticated-orcid":false,"given":"G.","family":"Pita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FJ.","family":"Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MC.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Nu\u00f1ez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4561-1505","authenticated-orcid":false,"given":"VJ.","family":"Sanchez-Arevalo Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3493-718X","authenticated-orcid":false,"given":"L.","family":"Alonso-Guirado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-3784","authenticated-orcid":false,"given":"N.","family":"Malats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5421-2020","authenticated-orcid":false,"given":"A.","family":"Gonzalez-Neira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6755-6017","authenticated-orcid":false,"given":"L.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3799-8823","authenticated-orcid":false,"given":"P.","family":"Roda-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9606-0398","authenticated-orcid":false,"given":"R.","family":"Torres-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7221-3636","authenticated-orcid":false,"given":"S.","family":"Rodriguez-Perales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"2542_CR1","doi-asserted-by":"publisher","unstructured":"Pons G, Gallo-Oller G, Navarro N, Zarzosa P, Sansa-Girona J, Garcia-Gilabert L, Magdaleno A, Segura MF, de Sanchez J, Gallego S, et al. Analysis of cancer genomic amplifications identifies druggable collateral dependencies within the amplicon. Cancers (Basel). 2023;15(6). https:\/\/doi.org\/10.3390\/cancers15061636.","DOI":"10.3390\/cancers15061636"},{"issue":"7848","key":"2542_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-020-03064-z","volume":"591","author":"O Shoshani","year":"2021","unstructured":"Shoshani O, Brunner SF, Yaeger R, Ly P, Nechemia-Arbely Y, Kim DH, Fang R, Castillon GA, Yu M, Li JSZ, et al. Chromothripsis drives the evolution of gene amplification in cancer. Nature. 2021;591(7848):137\u201341.","journal-title":"Nature"},{"issue":"5","key":"2542_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41568-019-0128-6","volume":"19","author":"RGW Verhaak","year":"2019","unstructured":"Verhaak RGW, Bafna V, Mischel PS. Extrachromosomal oncogene amplification in tumour pathogenesis and evolution. Nat Rev Cancer. 2019;19(5):283\u20138.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2542_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.trecan.2024.09.005","volume":"11","author":"VN Kadali","year":"2025","unstructured":"Kadali VN, Shoshani O. Aberrant nuclei with amplified DNA in cancer. Trends Cancer. 2025;11(1):9\u201311.","journal-title":"Trends Cancer"},{"issue":"1","key":"2542_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41422-024-01054-8","volume":"35","author":"QL Yang","year":"2025","unstructured":"Yang QL, Xie Y, Qiao K, Lim JYS, Wu S. Modern biology of extrachromosomal DNA: a decade-long voyage of discovery. Cell Res. 2025;35(1):11\u201322.","journal-title":"Cell Res"},{"issue":"1","key":"2542_CR6","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/s41467-025-56670-8","volume":"16","author":"S Raeisi Dehkordi","year":"2025","unstructured":"Raeisi Dehkordi S, Wong IT, Ni J, Luebeck J, Zhu K, Prasad G, Krockenberger L, Xu G, Chowdhury B, Rajkumar U, et al. Breakage fusion Bridge cycles drive high oncogene number with moderate intratumoural heterogeneity. Nat Commun. 2025;16(1):1497.","journal-title":"Nat Commun"},{"issue":"9","key":"2542_CR7","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1101\/gr.106252.110","volume":"20","author":"CT Storlazzi","year":"2010","unstructured":"Storlazzi CT, Lonoce A, Guastadisegni MC, Trombetta D, D\u2019Addabbo P, Daniele G, L\u2019Abbate A, Macchia G, Surace C, Kok K, et al. Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure. Genome Res. 2010;20(9):1198\u2013206.","journal-title":"Genome Res"},{"issue":"7643","key":"2542_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature21356","volume":"543","author":"KM Turner","year":"2017","unstructured":"Turner KM, Deshpande V, Beyter D, Koga T, Rusert J, Lee C, Li B, Arden K, Ren B, Nathanson DA, et al. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature. 2017;543(7643):122\u20135.","journal-title":"Nature"},{"issue":"9","key":"2542_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41588-020-0678-2","volume":"52","author":"H Kim","year":"2020","unstructured":"Kim H, Nguyen NP, Turner K, Wu S, Gujar AD, Luebeck J, Liu J, Deshpande V, Rajkumar U, Namburi S, et al. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nat Genet. 2020;52(9):891\u20137.","journal-title":"Nat Genet"},{"issue":"7890","key":"2542_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41586-021-04116-8","volume":"600","author":"KL Hung","year":"2021","unstructured":"Hung KL, Yost KE, Xie L, Shi Q, Helmsauer K, Luebeck J, Schopflin R, Lange JT, Chamorro Gonzalez R, Weiser NE, et al. EcDNA hubs drive cooperative intermolecular oncogene expression. Nature. 2021;600(7890):731\u20136.","journal-title":"Nature"},{"issue":"1","key":"2542_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41392-022-01176-8","volume":"7","author":"L Yang","year":"2022","unstructured":"Yang L, Jia R, Ge T, Ge S, Zhuang A, Chai P, Fan X. Extrachromosomal circular DNA: biogenesis, structure, functions and diseases. Signal Transduct Target Ther. 2022;7(1):342.","journal-title":"Signal Transduct Target Ther"},{"issue":"8037","key":"2542_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-024-07861-8","volume":"635","author":"KL Hung","year":"2024","unstructured":"Hung KL, Jones MG, Wong IT, Curtis EJ, Lange JT, He BJ, Luebeck J, Schmargon R, Scanu E, Bruckner L, et al. Coordinated inheritance of extrachromosomal DNAs in cancer cells. Nature. 2024;635(8037):201\u20139.","journal-title":"Nature"},{"issue":"10","key":"2542_CR13","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/s41588-022-01177-x","volume":"54","author":"JT Lange","year":"2022","unstructured":"Lange JT, Rose JC, Chen CY, Pichugin Y, Xie L, Tang J, Hung KL, Yost KE, Shi Q, Erb ML, et al. The evolutionary dynamics of extrachromosomal DNA in human cancers. Nat Genet. 2022;54(10):1527\u201333.","journal-title":"Nat Genet"},{"issue":"6166","key":"2542_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1126\/science.1241328","volume":"343","author":"DA Nathanson","year":"2014","unstructured":"Nathanson DA, Gini B, Mottahedeh J, Visnyei K, Koga T, Gomez G, Eskin A, Hwang K, Wang J, Masui K, et al. Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science. 2014;343(6166):72\u20136.","journal-title":"Science"},{"issue":"12","key":"2542_CR15","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1007\/s12094-019-02099-7","volume":"21","author":"E Ramos Elbal","year":"2019","unstructured":"Ramos Elbal E, Galera Minarro AM, Llinares Riestra ME, Bermudez Cortes M, Fuster Soler JL. Neuroblastoma: validation of the INRG classification system in a small series. Clin Transl Oncol. 2019;21(12):1776\u201380.","journal-title":"Clin Transl Oncol"},{"key":"2542_CR16","doi-asserted-by":"publisher","unstructured":"Smith V, Foster J. High-Risk neuroblastoma treatment review. Child (Basel). 2018;5(9). https:\/\/doi.org\/10.3390\/children5090114.","DOI":"10.3390\/children5090114"},{"issue":"4","key":"2542_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/14737140.2017.1285230","volume":"17","author":"SB Whittle","year":"2017","unstructured":"Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017;17(4):369\u201386.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"10","key":"2542_CR18","doi-asserted-by":"publisher","first-page":"e27257","DOI":"10.1002\/pbc.27257","volume":"65","author":"JW Lee","year":"2018","unstructured":"Lee JW, Son MH, Cho HW, Ma YE, Yoo KH, Sung KW, Koo HH. Clinical significance of MYCN amplification in patients with high-risk neuroblastoma. Pediatr Blood Cancer. 2018;65(10):e27257.","journal-title":"Pediatr Blood Cancer"},{"key":"2542_CR19","doi-asserted-by":"publisher","first-page":"624079","DOI":"10.3389\/fonc.2020.624079","volume":"10","author":"J Otte","year":"2020","unstructured":"Otte J, Dyberg C, Pepich A, Johnsen JI. MYCN function in neuroblastoma development. Front Oncol. 2020;10:624079.","journal-title":"Front Oncol"},{"issue":"1","key":"2542_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12967-017-1265-x","volume":"15","author":"Y Kwak","year":"2017","unstructured":"Kwak Y, Yun S, Nam SK, Seo AN, Lee KS, Shin E, Oh HK, Kim DW, Kang SB, Kim WH, et al. Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO\/CAP guideline criterion for HER2 testing of breast cancer. J Transl Med. 2017;15(1):167.","journal-title":"J Transl Med"},{"issue":"2","key":"2542_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2016.12.005","volume":"31","author":"G Mollaoglu","year":"2017","unstructured":"Mollaoglu G, Guthrie MR, Bohm S, Bragelmann J, Can I, Ballieu PM, Marx A, George J, Heinen C, Chalishazar MD, et al. MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to Aurora kinase Inhibition. Cancer Cell. 2017;31(2):270\u201385.","journal-title":"Cancer Cell"},{"issue":"1","key":"2542_CR22","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1038\/s41467-022-34000-6","volume":"13","author":"D Zimmerli","year":"2022","unstructured":"Zimmerli D, Brambillasca CS, Talens F, Bhin J, Linstra R, Romanens L, et al. MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling. Nat Commun. 2022;13(1):6579.","journal-title":"Nat Commun"},{"issue":"1","key":"2542_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41420-023-01403-3","volume":"9","author":"J Li","year":"2023","unstructured":"Li J, Dong T, Wu Z, Zhu D, Gu H. The effects of MYC on tumor immunity and immunotherapy. Cell Death Discov. 2023;9(1):103.","journal-title":"Cell Death Discov"},{"issue":"8037","key":"2542_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-024-07802-5","volume":"635","author":"J Tang","year":"2024","unstructured":"Tang J, Weiser NE, Wang G, Chowdhry S, Curtis EJ, Zhao Y, Wong IT, Marinov GK, Li R, Hanoian P, et al. Enhancing transcription-replication conflict targets ecDNA-positive cancers. Nature. 2024;635(8037):210\u20138.","journal-title":"Nature"},{"issue":"3","key":"2542_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1158\/2159-8290.CD-23-1189","volume":"14","author":"Y Bei","year":"2024","unstructured":"Bei Y, Brame L, Kirchner M, Fritsche-Guenther R, Kunz S, Bhattacharya A, Rusu MC, Gurgen D, Dubios FPB, Koppke JKC, et al. Passenger gene coamplifications create collateral therapeutic vulnerabilities in cancer. Cancer Discov. 2024;14(3):492\u2013507.","journal-title":"Cancer Discov"},{"key":"2542_CR26","doi-asserted-by":"publisher","unstructured":"Kwon T, Ra JS, Lee S, Baek IJ, Khim KW, Lee EA, Song EK, Otarbayev D, Jung W, Park YH et al. Precision targeting tumor cells using cancer-specific InDel mutations with CRISPR-Cas9. Proc Natl Acad Sci U S A. 2022;119(9). https:\/\/doi.org\/10.1073\/pnas.2103532119}","DOI":"10.1073\/pnas.2103532119"},{"issue":"1","key":"2542_CR27","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1038\/s41467-025-60160-2","volume":"16","author":"MB Hanlon","year":"2025","unstructured":"Hanlon MB, Shohet JM, Wolfe SA. Selective targeting of genome amplifications and repeat elements by CRISPR-Cas9 nickases to promote cancer cell death. Nat Commun. 2025;16(1):5126.","journal-title":"Nat Commun"},{"issue":"4","key":"2542_CR28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol. 2022;23(4):487\u2013500.","journal-title":"Nat Immunol"},{"key":"2542_CR29","doi-asserted-by":"publisher","first-page":"828657","DOI":"10.3389\/fcell.2021.828657","volume":"9","author":"R Shen","year":"2021","unstructured":"Shen R, Liu D, Wang X, Guo Z, Sun H, Song Y, Wang D. DNA damage and activation of cGAS\/STING pathway induce tumor microenvironment remodeling. Front Cell Dev Biol. 2021;9:828657.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"2542_CR30","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","volume":"11","author":"P Dey","year":"2021","unstructured":"Dey P, Kimmelman AC, DePinho RA. Metabolic codependencies in the tumor microenvironment. Cancer Discov. 2021;11(5):1067\u201381.","journal-title":"Cancer Discov"},{"issue":"1","key":"2542_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","volume":"22","author":"A da Costa","year":"2023","unstructured":"da Costa A, Chowdhury D, Shapiro GI, D\u2019Andrea AD, Konstantinopoulos PA. Targeting replication stress in cancer therapy. Nat Rev Drug Discov. 2023;22(1):38\u201358.","journal-title":"Nat Rev Drug Discov"},{"issue":"5\u20136","key":"2542_CR32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1101\/gad.349431.122","volume":"36","author":"JL Hopkins","year":"2022","unstructured":"Hopkins JL, Lan L, Zou L. DNA repair defects in cancer and therapeutic opportunities. Genes Dev. 2022;36(5\u20136):278\u201393.","journal-title":"Genes Dev"},{"issue":"1","key":"2542_CR33","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1038\/s41467-020-18875-x","volume":"11","author":"M Martinez-Lage","year":"2020","unstructured":"Martinez-Lage M, Torres-Ruiz R, Puig-Serra P, Moreno-Gaona P, Martin MC, Moya FJ, Quintana-Bustamante O, Garcia-Silva S, Carcaboso AM, Petazzi P, et al. In vivo CRISPR\/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells. Nat Commun. 2020;11(1):5060.","journal-title":"Nat Commun"},{"issue":"11","key":"2542_CR34","doi-asserted-by":"publisher","first-page":"113339","DOI":"10.1016\/j.celrep.2023.113339","volume":"42","author":"IL Tan","year":"2023","unstructured":"Tan IL, Perez AR, Lew RJ, Sun X, Baldwin A, Zhu YK, Shah MM, Berger MS, Doudna JA, Fellmann C. Targeting the non-coding genome and Temozolomide signature enables CRISPR-mediated glioma Oncolysis. Cell Rep. 2023;42(11):113339.","journal-title":"Cell Rep"},{"issue":"3","key":"2542_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"key":"2542_CR36","doi-asserted-by":"publisher","unstructured":"Bao R, Spranger S, Hernandez K, Zha Y, Pytel P, Luke JJ, Gajewski TF, Volchenboum SL, Cohn SL, Desai AV. Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma. J Immunother Cancer. 2021;9(7). https:\/\/doi.org\/10.1136\/jitc-2021-002417.","DOI":"10.1136\/jitc-2021-002417"},{"key":"2542_CR37","doi-asserted-by":"publisher","unstructured":"Rivera Z, Escutia C, Madonna MB, Gupta KH. Biological insight and recent advancement in the treatment of neuroblastoma. Int J Mol Sci. 2023;24(10). https:\/\/doi.org\/10.1136\/ijms24108470.","DOI":"10.1136\/ijms24108470"},{"key":"2542_CR38","doi-asserted-by":"publisher","unstructured":"Seier JA, Reinhardt J, Saraf K, Ng SS, Layer JP, Corvino D, Althoff K, Giordano FA, Schramm A, Fischer M, et al. Druggable epigenetic suppression of interferon-induced chemokine expression linked to MYCN amplification in neuroblastoma. J Immunother Cancer. 2021;9(5). https:\/\/doi.org\/10.1136\/jitc-2020-001335.","DOI":"10.1136\/jitc-2020-001335"},{"issue":"8037","key":"2542_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41586-024-08107-3","volume":"635","author":"C Bailey","year":"2024","unstructured":"Bailey C, Pich O, Thol K, Watkins TBK, Luebeck J, Rowan A, Stavrou G, Weiser NE, Dameracharla B, Bentham R, et al. Origins and impact of extrachromosomal DNA. Nature. 2024;635(8037):193\u2013200.","journal-title":"Nature"},{"issue":"10","key":"2542_CR40","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1158\/1078-0432.CCR-15-1449","volume":"22","author":"A Henssen","year":"2016","unstructured":"Henssen A, Althoff K, Odersky A, Beckers A, Koche R, Speleman F, Schafers S, Bell E, Nortmeyer M, Westermann F, et al. Targeting MYCN-Driven transcription by BET-Bromodomain Inhibition. Clin Cancer Res. 2016;22(10):2470\u201381.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2542_CR41","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1158\/0008-5472.CAN-17-2011","volume":"78","author":"D Shiraishi","year":"2018","unstructured":"Shiraishi D, Fujiwara Y, Horlad H, Saito Y, Iriki T, Tsuboki J, Cheng P, Nakagata N, Mizuta H, Bekki H, et al. CD163 is required for protumoral activation of macrophages in human and murine sarcoma. Cancer Res. 2018;78(12):3255\u201366.","journal-title":"Cancer Res"},{"issue":"1","key":"2542_CR42","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13046-023-02913-9","volume":"42","author":"MC Stip","year":"2023","unstructured":"Stip MC, Teeuwen L, Dierselhuis MP, Leusen JHW, Krijgsman D. Targeting the myeloid microenvironment in neuroblastoma. J Exp Clin Cancer Res. 2023;42(1):337.","journal-title":"J Exp Clin Cancer Res"},{"key":"2542_CR43","doi-asserted-by":"publisher","unstructured":"Wu X, Nelson M, Basu M, Srinivasan P, Lazarski C, Zhang P, Zheng P, Sandler AD. MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination. J Immunother Cancer. 2021;9(3). https:\/\/doi.org\/10.1136\/jitc-2020-001388.","DOI":"10.1136\/jitc-2020-001388"},{"issue":"8","key":"2542_CR44","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/s41589-023-01279-5","volume":"19","author":"YH Kim","year":"2023","unstructured":"Kim YH, Kim N, Okafor I, Choi S, Min S, Lee J, Bae SM, Choi K, Choi J, Harihar V, et al. Sniper2L is a high-fidelity Cas9 variant with high activity. Nat Chem Biol. 2023;19(8):972\u201380.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"2542_CR45","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/nar\/gkad1125","volume":"52","author":"H Zhang","year":"2024","unstructured":"Zhang H, Kelly K, Lee J, Echeverria D, Cooper D, Panwala R, Amrani N, Chen Z, Gaston N, Wagh A, et al. Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo. Nucleic Acids Res. 2024;52(2):977\u201397.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2542_CR46","doi-asserted-by":"publisher","first-page":"e2307801120","DOI":"10.1073\/pnas.2307801120","volume":"121","author":"A Radmand","year":"2024","unstructured":"Radmand A, Kim H, Beyersdorf J, Dobrowolski CN, Zenhausern R, Paunovska K, Huayamares SG, Hua X, Han K, Loughrey D, et al. Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart. Proc Natl Acad Sci U S A. 2024;121(11):e2307801120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2542_CR47","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41565-024-01851-7","volume":"20","author":"S Ling","year":"2025","unstructured":"Ling S, Zhang X, Dai Y, Jiang Z, Zhou X, Lu S, et al. Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington\u2019s disease gene therapy. Nat Nanotechnol. 2025;20(4):543\u201353.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"2542_CR48","doi-asserted-by":"publisher","first-page":"2437918","DOI":"10.1080\/21645515.2024.2437918","volume":"20","author":"L Dou","year":"2024","unstructured":"Dou L, Fang Y, Yang H, Ai G, Shen N. Immunogenic cell death: A new strategy to enhancing cancer immunotherapy. Hum Vaccin Immunother. 2024;20(1):2437918.","journal-title":"Hum Vaccin Immunother"},{"key":"2542_CR49","doi-asserted-by":"publisher","first-page":"217079","DOI":"10.1016\/j.canlet.2024.217079","volume":"598","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Mai Y, Zhang G, Wang Y, Sun P, Jing Z, Li Z, Xu Y, Han B, Liu J. Emerging role of Immunogenic cell death in cancer immunotherapy: advancing next-generation CAR-T cell immunotherapy by combination. Cancer Lett. 2024;598:217079.","journal-title":"Cancer Lett"},{"issue":"1","key":"2542_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/onc.2015.70","volume":"35","author":"S Rodriguez-Perales","year":"2016","unstructured":"Rodriguez-Perales S, Torres-Ruiz R, Suela J, Acquadro F, Martin MC, Yebra E, Ramirez JC, Alvarez S, Cigudosa JC. Truncated RUNX1 protein generated by a novel t(1;21)(p32;q22) chromosomal translocation impairs the proliferation and differentiation of human hematopoietic progenitors. Oncogene. 2016;35(1):125\u201334.","journal-title":"Oncogene"},{"issue":"1","key":"2542_CR51","first-page":"210","volume":"12","author":"P Konda","year":"2022","unstructured":"Konda P, Roque Iii JA, Lifshits LM, Alcos A, Azzam E, Shi G, Cameron CG, McFarland SA, Gujar S. Photodynamic therapy of melanoma with new, structurally similar, NIR-absorbing ruthenium (II) complexes promotes tumor growth control via distinct hallmarks of Immunogenic cell death. Am J Cancer Res. 2022;12(1):210\u201328.","journal-title":"Am J Cancer Res"},{"issue":"12","key":"2542_CR52","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1038\/s41596-021-00626-x","volume":"16","author":"NL Malinin","year":"2021","unstructured":"Malinin NL, Lee G, Lazzarotto CR, Li Y, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Iafrate AJ, Le LP, et al. Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq. Nat Protoc. 2021;16(12):5592\u2013615.","journal-title":"Nat Protoc"},{"issue":"5","key":"2542_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nbt.3534","volume":"34","author":"SQ Tsai","year":"2016","unstructured":"Tsai SQ, Topkar VV, Joung JK, Aryee MJ. Open-source Guideseq software for analysis of GUIDE-seq data. Nat Biotechnol. 2016;34(5):483.","journal-title":"Nat Biotechnol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02542-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02542-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02542-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T04:50:01Z","timestamp":1770267001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02542-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2542"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02542-0","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments with mice conformed to Animal Welfare guidelines and were performed in accordance to protocols approved by the Ethics Committee of the Instituto de Salud Carlos III (No. IACUC.001-2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}